Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class ASSE: 603168

Report for Q1 2026

· Issued by Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Report for Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class A

All Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class A news releases